Lewis Atkinson

The Government has called for widespread adoption of the live music sector’s £1 voluntary ticket contribution to help safeguard the future of the grassroots music sector. We want to see the levy in place for as many stadium and arena shows in 2026 as possible, and we continue to urge major promoters, venues, and artists to step up.

The Government welcomes the commitment already made by many, and is encouraged to see that the LIVE Trust has already distributed over £500,000 in levy funding to industry programmes and is projected to receive a total of £10 million in 2026.

However, we want to see uptake increase further, and have consistently said that we are prepared to explore legislative options if required to ensure the sustainability of our world-leading live music industry.

I refer the hon. Member to the reply given to the hon. Member for Manchester Rusholme, Afzal Khan, on 20 October 2025, PQ UIN 78472.

Network Rail has apologised for the frustration and inconvenience caused to the people of Sunderland. It has conducted an investigation of the issues raised, and I am aware that Northern is working with the honourable member to improve various aspects of the station.

To aid retention and to encourage existing driving examiners (DE) to stay in role, the Driver and Vehicle Standards Agency (DVSA) is making an exceptional payment of £5,000 to DEs and eligible roles (divided into two payments) over the next 12 months. By keeping more experienced driving examiners and bringing in new ones, DVSA will lose less testing capacity from the system, making more tests available for learner drivers.

Examiner capacity is rising, with 1,542 FTE examiners now in post (the highest since 2021) as of December 2025.

DEs are civil servants and as such, their salary is determined by the Civil Service Pay Remit Guidance. The guidance sets out the financial parameters Civil Service departments can use to determine pay awards for their staff. DVSA cannot act independently from this guidance. DVSA continues to look at different financial incentives to recruit examiners and, indeed, to offer to existing employees conducting tests.

The attached excel spreadsheet shows the (a) average and (b) highest waiting time for driving test centres (DTC) in the North East of England, from the financial year 2015/16 to the financial year-to-date (YTD). Please note, that DVSA does not hold data for Elswick and South Shields DTCs beyond 2022/23, due to these centres closing.

To aid retention and to encourage existing driving examiners (DE) to stay in role, the Driver and Vehicle Standards Agency (DVSA) is making an exceptional payment of £5,000 to DEs and eligible roles (divided into two payments) over the next 12 months. By keeping more experienced driving examiners and bringing in new ones, DVSA will lose less testing capacity from the system, making more tests available for learner drivers.

Examiner capacity is rising, with 1,542 FTE examiners now in post (the highest since 2021) as of December 2025.

DEs are civil servants and as such, their salary is determined by the Civil Service Pay Remit Guidance. The guidance sets out the financial parameters Civil Service departments can use to determine pay awards for their staff. DVSA cannot act independently from this guidance. DVSA continues to look at different financial incentives to recruit examiners and, indeed, to offer to existing employees conducting tests.

The attached excel spreadsheet shows the (a) average and (b) highest waiting time for driving test centres (DTC) in the North East of England, from the financial year 2015/16 to the financial year-to-date (YTD). Please note, that DVSA does not hold data for Elswick and South Shields DTCs beyond 2022/23, due to these centres closing.

The table below shows the current average waiting time in weeks and the number of tests available at Sunderland, Gateshead, Gosforth and Durham driving test centres (DTC) as of 24 November 2025.

The Driver and Vehicle Standards Agency (DVSA) is continuing with recruitment campaigns across the country to provide as many tests as possible. A full-time driving examiner (DE) can be expected to add approximately 1,200 tests per year to the booking system.

Since May 2025, DVSA has recruited two new entrant examiners for Sunderland, two new entrants for Gateshead, one new entrant for Gosforth, and one new entrant for Durham. There are also two new entrants undertaking training who are earmarked for Gosforth.

From DVSA’s most recent recruitment campaign, DVSA advertised for further examiner positions for DTCs in the area and is starting to make employment offers, with the hope to have further new entrants in post early in 2026, after all pre-employment checks and training have been successfully completed.

DVSA will also be advertising for further examiner positions in the next recruitment campaign, scheduled to launch next month.

The Government acknowledges the challenges faced by women with endometriosis and the impact it has on their lives, their relationships and their participation in education and the workforce. We are committed to improving waiting times for diagnosis and treatment so patients can get the care they need sooner.

For women with severe endometriosis, NHS England commissions specialised services through 61 accredited hospitals contracted to deliver care in line with the current service specification. These are accredited by the British Society for Gynaecological Endoscopy. A revised specification is progressing through NHS governance and commissioning processes, ahead of consideration by the Clinical Priorities Advisory Group in 2026/27.

The revised specification will introduce a networked model of care to ensure all patients with endometriosis have access to clinicians with appropriate expertise, including through primary care, community services, and secondary care settings. This will improve the standards of care for women with severe endometriosis by ensuring specialist endometriosis services have access to the most up-to-date evidence and advice.

Research has led to new treatments being made available, including the National Institute for Health and Care Excellence approval of two pills to treat endometriosis in 2025, namely Relugolix and Linzagolix. Both are estimated to help approximately 1,000 women with severe endometriosis for whom other treatment options have not been effective.

Endometriosis is also identified as a priority condition in the Renewed Women’s Health Strategy, where women experience unacceptably long delays to diagnosis, pain being dismissed, and fragmented care.

The six National Health Service neighbourhood mental health centres currently being piloted will bring together a range of community mental health services under one roof, including crisis services and short-stay beds. People with serious mental illness such as schizophrenia or bipolar disorder will be able to walk in without an appointment if they need mental health support, as well as advice on employment, housing, or volunteering, delivered by a multi-disciplinary team.

The pilot sites will allow us to test the extent of the benefits this model will realise in this country, but we still expect it to be an improvement as it has demonstrated positive outcomes and efficiencies in other health systems across the globe.

While the evaluation of the six pilots will not be available until next year, evidence from comparable international models shows an association with positive outcomes such as reduced admissions and length of stay.

The Department is aware of several limitations that apply to drug-related death statistics. These include the limitation that figures reported for specific substances are undercounts as it is not always possible to determine which drugs were involved from information provided on death certificates. This is a limitation the Office for National Statistics acknowledges in their drug poisoning statistical publications. However, drug related deaths where the specific substances involved have not been recorded are still included within overall counts of drug poisonings, which the Department also monitors. Furthermore, it is clear from the deaths where sufficient information is known that opioids are involved in a substantial majority of drug-related deaths in England. This understanding underpins our policy decisions.

Waiting time data for community adult mental health services is already routinely published.

Since July 2023, NHS England has included waiting time metrics for referrals to community-based mental health services in its monthly mental health statistics publication, to help services target the longest waits. The latest information on wait times is available at the following link:

https://digital.nhs.uk/data-and-information/publications/statistical/nhs-talking-therapies-monthly-statistics-including-employment-advisors

Naloxone is a lifesaving medicine that reverses the effects of an opioid overdose, including for highly potent synthetic opioids which are growing in prevalence in the United Kingdom. It is more important than ever to increase access to naloxone products, which will save lives.

The Department recently amended the Human Medicines Regulations 2012 to further expand access to naloxone. The legislation will mean more services and professionals are able to supply this medication, which in turn means easier access to it for people at risk, and for their loved ones. This legislation came into force in early December 2024.

Route one of the legislation increased the number of services and professionals specified in regulations who can provide ‘take home naloxone’. However, not all services and professions have an agreed statutory definition across the four nations of the UK. As such, route two of the legislation set up the legal framework, which includes supply network coordinators, for the creation of a registration service for services and professions who fall outside of the definitions listed in route one to apply and to be able to provide take home naloxone. The Government is continuing to work with the devolved administrations and front-line services to explore the set-up and delivery of this registration service and to help deliver wider access to naloxone for all who need it.

The Department has also recently published the guidance, Supplying take home naloxone without a prescription, that sets out essential practical information such as who can supply naloxone, the products available, how to use naloxone and other basic lifesaving tools, and the training required. The guidance is available at the following link:

https://www.gov.uk/guidance/supplying-take-home-naloxone-without-a-prescription